相关实验视频
Updated: Sep 15, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
357
用提尔泽帕提德成功治疗下丘脑肥胖症
Sharmela Brijmohan1, Jamie A Mullally1
1Westchester Medical Center. Endocrinology, Diabetes and Metabolism, School of Medicine, New York Medical College, Valhalla, New York.
AACE endocrinology and diabetes
|July 18, 2025
概括
蒂尔泽帕提德为下丘脑肥胖症 (HO) 提供了一种新的治疗方法,这是一个严重的疾病,通常是由瘤引起的. 这项研究表明,HO患者的体重管理成功,突出了tirzepatide.
科学领域:
- 内分泌学 在内分泌学.
- 神经瘤学神经瘤学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 脑下垂体肥胖 (HO) 是一种严重的内分泌疾病,由脑下垂体损伤引起,通常是由于瘤.
- HO导致吞过量和减少能量消耗,对传统的减肥疗法具有抗性.
- 膜瘤是HO的常见原因,需要有效的治疗策略.
研究的目的:
- 报告一个成功治疗下丘脑肥胖症的新案例,使用蒂尔泽帕提德.
- 为了探索tirzepatide在管理HO复杂的病理生理学方面的潜力.
主要方法:
- 一名21岁的男性患有HO脑瘤后切除,接受了提尔泽帕提德治疗.
- 提尔泽帕提德剂量在4个月内逐渐增加到10毫克.
主要成果:
- 患者经历了显著的体重减轻 (9公斤) 和BMI降低 (从40到37公斤/米2).
- 蒂尔泽帕提德在管理与HO相关的体重增加和过方面表现出有效性.
结论:
- 蒂尔泽帕提德代表着对下丘脑肥胖症的一个有前途的治疗选择.
- 需要进一步的研究来证实蒂尔泽帕提德在HO管理中的有效性和作用.
相关概念视频
01:24Obesity
621
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
621
01:37Hypothalamic-Pituitary Axis
61.7K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
61.7K